Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,734 | 57 | 50.1% |
| Travel and Lodging | $2,724 | 7 | 49.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $1,677 | 11 | $0 (2023) |
| Penumbra, Inc. | $1,461 | 6 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $747.93 | 21 | $0 (2020) |
| Rapid Medical Ltd | $283.00 | 1 | $0 (2021) |
| Medicure Pharma Inc. | $218.67 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $120.06 | 1 | $0 (2018) |
| Allergan, Inc. | $117.06 | 1 | $0 (2020) |
| Chiesi USA, Inc. | $113.07 | 1 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $110.43 | 2 | $0 (2018) |
| CARDIVA MEDICAL, INC. | $99.83 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $93.55 | 2 | Stryker Corporation ($71.70) |
| 2022 | $69.62 | 4 | Boston Scientific Corporation ($49.44) |
| 2021 | $283.00 | 1 | Rapid Medical Ltd ($283.00) |
| 2020 | $427.62 | 5 | Stryker Corporation ($260.00) |
| 2019 | $2,103 | 28 | Stryker Corporation ($1,325) |
| 2018 | $2,189 | 20 | Penumbra, Inc. ($1,461) |
| 2017 | $292.08 | 4 | CARDIVA MEDICAL, INC. ($99.83) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2023 | Stryker Corporation | TREVO (Device) | Food and Beverage | In-kind items and services | $71.70 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 02/22/2023 | Azurity Pharmaceuticals, Inc. | Nymalize (Drug) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Neurology | ||||||
| 08/03/2022 | Stryker Corporation | TREVO (Device) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 05/05/2022 | Boston Scientific Corporation | Infinion 16 (Device) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Infinion_NMD | ||||||
| 03/14/2022 | Boston Scientific Corporation | Carotid WALLSTENT (Device) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Carotid WALLSTENT_PI | ||||||
| 02/21/2022 | Boston Scientific Corporation | Epic Vascular (Device) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Epic_PI | ||||||
| 07/28/2021 | Rapid Medical Ltd | COMANECI 17 (Device), TIGERTRIEVER 17 REVASCULARIZATION DEVICE | Food and Beverage | Cash or cash equivalent | $283.00 | General |
| Category: neurovascular | ||||||
| 08/19/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/09/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/09/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $117.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/19/2020 | Stryker Corporation | TARGET (Device) | Travel and Lodging | Cash or cash equivalent | $260.00 | General |
| Category: DETACHABLE COIL | ||||||
| 02/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2019 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $113.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $90.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/30/2019 | Medtronic USA, Inc. | Solitaire (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Stents | ||||||
| 08/06/2019 | Stryker Corporation | NEUROFORM EZ (Device), TARGET, ATLAS | Travel and Lodging | Cash or cash equivalent | $557.76 | General |
| Category: STENT | ||||||
| 06/26/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2019 | Stryker Corporation | CATALYST (Device) | Food and Beverage | Cash or cash equivalent | $29.78 | General |
| Category: CATHETER | ||||||
| 06/21/2019 | Stryker Corporation | TREVO (Device) | Food and Beverage | Cash or cash equivalent | $28.23 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 06/20/2019 | Stryker Corporation | TARGET (Device) | Food and Beverage | Cash or cash equivalent | $108.44 | General |
| Category: DETACHABLE COIL | ||||||
| 06/20/2019 | Stryker Corporation | NEUROFORM EZ (Device) | Food and Beverage | Cash or cash equivalent | $32.90 | General |
| Category: STENT | ||||||
| 06/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2019 | Stryker Corporation | CATALYST (Device) | Travel and Lodging | Cash or cash equivalent | $526.30 | General |
| Category: CATHETER | ||||||
| 06/14/2019 | Stryker Corporation | CATALYST (Device) | Food and Beverage | Cash or cash equivalent | $27.78 | General |
| Category: CATHETER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 84 | 124 | $24,532 | $11,479 |
| 2022 | 3 | 58 | 115 | $19,425 | $6,835 |
| 2020 | 2 | 26 | 26 | $44,461 | $11,580 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 52 | $15,028 | $7,036 | 46.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 72 | $9,504 | $4,443 | 46.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 83 | $14,525 | $4,659 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 17 | $3,400 | $1,717 | 50.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 15 | $1,500 | $459.95 | 30.7% |
| 61645 | Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance, accessed through skin | Facility | 2020 | 15 | 15 | $34,030 | $8,756 | 25.7% |
| 36226 | Insertion of catheter into chest artery for diagnosis or treatment including radiological supervision and interpretation | Facility | 2020 | 11 | 11 | $10,431 | $2,824 | 27.1% |
About Dr. Elwaleed Elnour, MD
Dr. Elwaleed Elnour, MD is a Neurocritical Care healthcare provider based in Duncanville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659569390.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elwaleed Elnour, MD has received a total of $5,458 in payments from pharmaceutical and medical device companies, with $93.55 received in 2023. These payments were reported across 64 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,734).
As a Medicare-enrolled provider, Elnour has provided services to 168 Medicare beneficiaries, totaling 265 services with total Medicare billing of $29,895. Data is available for 3 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Neurocritical Care
- Other Specialties Neurology, Vascular Neurology
- Location Duncanville, TX
- Active Since 10/09/2007
- Last Updated 06/25/2025
- Taxonomy Code 2084A2900X
- Entity Type Individual
- NPI Number 1659569390
Products in Payments
- Penumbra System (Device) $1,421
- XARELTO (Drug) $832.13
- NEUROFORM EZ (Device) $590.66
- CATALYST (Device) $583.86
- TARGET (Device) $368.44
- COMANECI 17 (Device) $283.00
- Aggrastat (tirofiban HCl) (Drug) $218.67
- TREVO (Device) $120.11
- ELIQUIS (Drug) $120.06
- TEFLARO (Drug) $117.06
- CLEVIPREX (Drug) $113.07
- NUEDEXTA (Drug) $110.43
- Vascular Closure Device (Device) $99.83
- SAMSCA (Drug) $94.56
- PULSERIDER (Device) $72.68
- Briviact (Drug) $57.53
- 3D Revascularization (Device) $40.00
- Solitaire (Device) $36.24
- ANDEXXA (Biological) $35.29
- BEVYXXA (Drug) $26.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.